TCM
RMD icon

Tuttle Capital Management’s ResMed RMD Stock Holding History

Tuttle Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,544
Closed -$494K – 353
2021
Q1 		$494K Buy
+2,544
New +$510K 0.2% 132
2020
Q3 		– Sell
-1,560
Closed -$300K – 177
2020
Q2 		$300K Buy
+1,560
New +$255K 0.21% 104
2020
Q1 		– Sell
-10,100
Closed -$1.56M – 114
2019
Q4 		$1.56M Buy
10,100
+6,810
+207% +$982K 0.59% 35
2019
Q3 		$458K Buy
+3,290
New +$431K 0.12% 167

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tuttle Capital Management's RMD Position: Q2 2021 in Review

Tuttle Capital Management sold out of ResMed (RMD) in Q2 2021, closing a stake of 2,544 shares — an estimated $494K sold.

Tuttle Capital Management first reported a position in RMD in Q3 2019 and held it in 4 quarters. The position peaked at $1.56M in Q4 2019. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Tuttle Capital Management reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 2,544 ResMed shares in Q2 2021, an estimated $494K.
  • Tuttle Capital Management first reported a position in ResMed in Q3 2019 and held it in 4 quarters.
  • Tuttle Capital Management's ResMed position peaked at $1.56M in Q4 2019.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Tuttle Capital Management's 13F filing for Q2 2021, filed 21 Jul 2021.